Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/8/24 18:50 | 10/4/24 | MLTX | Financ | InvAdv | Investment Advice | Bvf Partners L P/Il | CA | DT | 1 | S.d | -100,003 | 50.00 | 0 | -2,000 | 1,288 | D | ||||||||||||||||
10/8/24 16:01 | 10/4/24 | MLTX | Health | Drug | Pharmaceutical Preparations | Sturge Simon | V8 | D | 1 | S | -9,186 | 53.72 | 0 | -171 | 172 | D | ||||||||||||||||
2/29/24 19:56 | 2/27/24 | MLTX | Health | Drug | Pharmaceutical Preparations | Santos Da Silva Jorge | V8 | DO | CEO | 3 | S.m | -10,421 | 56.41 | 0 | -185 | 3,108 | D | |||||||||||||||
2/29/24 19:53 | 2/27/24 | MLTX | Health | Drug | Pharmaceutical Preparations | Reich Kristian | V8 | O | Chief Sc | 3 | S.m | -11,404 | 57.02 | 0 | -200 | 3,108 | M | |||||||||||||||
12/21/23 16:01 | 12/19/23 | MLTX | Health | Drug | Pharmaceutical Preparations | Bodenstedt Matthias | V8 | O | CFO | 1 | S.m | -5,917 | 59.17 | 0 | -100 | 521 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |